Metraipolis › archive › dc_e7a2381ea185

CRISPR/Cas9 screen identifies DCAF4 as a novel protector of hepatocellular carcinoma against brachytherapy via stress granule-dependent NRF2 activation — Europe PMC PMID:42449099

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42449099
DOI
10.1038/s41419-[numero omesso]-0
License (as archived)
solo-consultazione
Archived
2026-10-18T07:21:40.237Z
SHA-256 of the archived text
efa72da76800310838728d54d7f93b44252f9813e2affbf24e43bddc6c124bee
Stable URL of this page
https://metraipolis.com/documento/dc_e7a2381ea185

How to cite

CRISPR/Cas9 screen identifies DCAF4 as a novel protector of hepatocellular carcinoma against brachytherapy via stress granule-dependent NRF2 activation — Europe PMC PMID:42449099 — Europe PMC (en), https://europepmc.org/article/MED/42449099 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e7a2381ea185 (Metraipolis archive dc_e7a2381ea185, sha256 efa72da76800310838728d54d7f93b44252f9813e2affbf24e43bddc6c124bee)
BibTeX
@misc{dce7a2381ea185,
  title = {CRISPR/Cas9 screen identifies DCAF4 as a novel protector of hepatocellular carcinoma against brachytherapy via stress granule-dependent NRF2 activation — Europe PMC PMID:42449099},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42449099},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e7a2381ea185; sha256 efa72da76800310838728d54d7f93b44252f9813e2affbf24e43bddc6c124bee},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42449099. Agents can read the archived copy with the MCP tool read_document.